[Evolution of the number of incident cases, stage and first treatments for prostate cancer in France between 2001 and 2016].
CONCLUSION: The evolution of the incident cases showed a decrease from 2006 to 2013 and a stability until 2016. The number of cases with PSA<10 ng/mL decreased since 2010 and the proportion of the options of treatment by surveillance increased strongly to the detriment of the surgery for low risks.
LEVEL OF EVIDENCE: 3.
PMID: 30638756 [PubMed - as supplied by publisher]
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
More News: Cancer | Cancer & Oncology | France Health | Prostate Cancer | Study | Urology & Nephrology